Advanced search
Publication Cover
Leukemia & Lymphoma Volume 49, 2008 - Issue 7
Submit an article Journal homepage
296
Views
20
CrossRef citations to date
0
Altmetric
Original Articles: Clinical

Delays in referral and diagnosis for chronic hematologic malignancies: A literature review

Gregory A. Abel Department of Medical Oncology, Center for Outcomes and Policy Research, Dana-Farber Cancer Institute, Boston, MACorrespondence[email protected]
,
Christopher R. Friese Department of Medical Oncology, Center for Outcomes and Policy Research, Dana-Farber Cancer Institute, Boston, MA
,
Lysa S. Magazu Department of Medical Oncology, Center for Outcomes and Policy Research, Dana-Farber Cancer Institute, Boston, MA
,
Lisa C. Richardson Division of Cancer Prevention and Control, Center for Disease Control, Atlanta, GA
,
Maria E. Fernandez School of Public Health, University of Texas at Houston, Houston, TX
,
Juan Jaime De Zengotita Department of Internal Medicine, Brigham and Women's Hospital, Boston, MA
&
Craig C. Earle Department of Medical Oncology, Center for Outcomes and Policy Research, Dana-Farber Cancer Institute, Boston, MA
 show all
Pages 1352-1359 | Received 04 Nov 2007, Accepted 12 Apr 2008, Published online: 01 Jul 2009

Citations (20)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Christopher R. Friese, Gregory A. Abel, Lysa S. Magazu, Bridget A. Neville, Lisa C. Richardson & Craig C. Earle. (2009) Diagnostic delay and complications for older adults with multiple myeloma. Leukemia & Lymphoma 50:3, pages 392-400.
Read now

Articles from other publishers (19)

Alba Bello Castro, Juan Seoane, Máximo Francisco Fraga Rodríguez, Francisco Gude Sampedro, Javier Seoane Romero, Benjamín Martin-Biedma & Pablo Castelo-Baz. (2022) Diagnostic Interval in Extranodal Non-Hodgkin Head and Neck Lymphomas. Journal of Clinical Medicine 11:3, pages 853.
Crossref
Covadonga Quirós, Ariana Fonseca, Sara Alonso-Álvarez, Marco Antonio Moro-García, Rebeca Alonso-Arias, Lucía-Rita Morais, Francisco V. Álvarez-Menendez & Enrique Colado. (2021) Development of an algorithm for the identification of leukemic hematolymphoid neoplasms in Primary Care patients. Diagnosis 8:2, pages 239-247.
Crossref
Alex Fauer, Sung Won Choi, Lauren P. Wallner, Matthew A. Davis & Christopher R. Friese. (2021) Understanding quality and equity: patient experiences with care in older adults diagnosed with hematologic malignancies. Cancer Causes & Control 32:4, pages 379-389.
Crossref
Rachel Offenbacher, Miriam A. Knoll & David M. Loeb. (2020) Delayed presentations of pediatric solid tumors at a tertiary care hospital in the Bronx due to COVID‐19. Pediatric Blood & Cancer 68:2.
Crossref
Austėja Dapkevičiūtė, Virginijus Šapoka, Elena Martynova & Valdas Pečeliūnas. (2019) Time from Symptom Onset to Diagnosis and Treatment among Haematological Malignancies: Influencing Factors and Associated Negative Outcomes. Medicina 55:6, pages 238.
Crossref
Joanna C. Zurko, Raymond C. Wade & Amitkumar Mehta. (2019) The impact of structural factors on diagnostic delay in diffuse large B‐cell lymphoma. Cancer Medicine 8:4, pages 1416-1422.
Crossref
Susan Baxter & Christopher J. McDermott. (2017) Decision-making and referral processes for patients with motor neurone disease: a qualitative study of GP experiences and evaluation of a new decision-support tool. BMC Health Services Research 17:1.
Crossref
Elise Launay, Jérémie F. Cohen, Michèle Morfouace, Christèle Gras-Le Guen, Philippe Ravaud & Martin Chalumeau. (2016) Inadequate critical appraisal of studies in systematic reviews of time to diagnosis. Journal of Clinical Epidemiology 78, pages 43-51.
Crossref
Anna Nikonova, Hany R. Guirguis, Rena Buckstein & Matthew C. Cheung. (2015) Predictors of delay in diagnosis and treatment in diffuse large B-cell lymphoma and impact on survival. British Journal of Haematology 168:4, pages 492-500.
Crossref
Nicole M Engel-Nitz, Benjamin Eckert, Rui Song, Priyanka Koka, Erin M Hulbert, Jeffrey McPheeters & April Teitelbaum. (2014) Diagnostic testing managed by hematopathology specialty and other laboratories: costs and patient diagnostic outcomes. BMC Clinical Pathology 14:1.
Crossref
Xavier Bosch, Emmanuel Coloma, Carolina Donate, Lluís Colomo, Pamela Doti, Anna Jordán & Alfonso López-Soto. (2014) Evaluation of Unexplained Peripheral Lymphadenopathy and Suspected Malignancy Using a Distinct Quick Diagnostic Delivery Model. Medicine 93:16, pages e95.
Crossref
Zoe K. McQuilten, Erica M. Wood, Mark N. Polizzotto, Lynda J. Campbell, Meaghan Wall, David J. Curtis, Helen Farrugia, John J. McNeil & Vijaya Sundararajan. (2014) Underestimation of myelodysplastic syndrome incidence by cancer registries: Results from a population-based data linkage study. Cancer 120:11, pages 1686-1694.
Crossref
Matthew Mccoyd, Gregory Gruener & Patrick Foy. 2014. Neurologic Aspects of Systemic Disease Part II. Neurologic Aspects of Systemic Disease Part II 1027 1043 .
Gregory A. Abel, Christopher R. Friese, Bridget A. Neville, Katherine M. Wilson, B. Taylor Hastings, Craig C. Earle, Nancy L. Keating & Lisa C. Richardson. (2012) Referrals for suspected hematologic malignancy: A survey of primary care physicians. American Journal of Hematology 87:6, pages 634-636.
Crossref
S.S. Raab. (2012) Timeliness and Quality of Diagnostic Care for Medicare Recipients With Chronic Lymphocytic Leukemia. Yearbook of Pathology and Laboratory Medicine 2012, pages 252-253.
Crossref
Christopher R. Friese, Craig C. Earle, Lysa S. Magazu, Jennifer R. Brown, Bridget A. Neville, Nathanael D. Hevelone, Lisa C. Richardson & Gregory A. Abel. (2010) Timeliness and quality of diagnostic care for medicare recipients with chronic lymphocytic leukemia. Cancer 117:7, pages 1470-1477.
Crossref
Matthew McCoyd & Gregory Gruener. (2011) Neurologic Aspects of Lymphoma and Leukemias. CONTINUUM: Lifelong Learning in Neurology 17, pages 73-94.
Crossref
Gregory A Abel, Kimberly A Bertrand, Craig C Earle & Francine Laden. (2009) Outcomes for lymphoid malignancies in the Nurses' Health Study (NHS) as compared to the Surveillance, Epidemiology and End Results (SEER) Program. Hematological Oncology 28:3, pages 133-136.
Crossref
. (2008) Current Awareness in Hematological Oncology. Hematological Oncology 26:4, pages 253-260.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.